Healthcare -
Biotechnology - NASDAQ - US
$ 2.28
-3.8 %
$ 60.5 M
Market Cap
-2.13
P/E
GANX - STOCK-BASED COMPENSATION
Stock-based Compensation GANX - Gain Therapeutics, Inc.
3.26 M
LAST VALUE
97.05%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR